Mysulin R Injection 100 IU/ml contains Insulin Human [rDNA], a rapid-acting, recombinant DNA-derived insulin for the management of diabetes mellitus. This high-concentration formulation provides effective postprandial blood glucose control and is suitable for patients requiring precise and predictable insulin dosing. Mysulin R 100 IU/ml is widely used in both type 1 and type 2 diabetes to prevent hyperglycemia and maintain optimal glycemic levels.

Insulin Human [rDNA] is produced through recombinant DNA technology, offering a pure, consistent, and highly reliable alternative to animal insulin. It mimics the natural action of human insulin, enhancing glucose uptake by tissues, reducing liver glucose production, and regulating overall blood sugar levels. The rapid onset of action ensures effective management of blood glucose spikes after meals, while its predictable pharmacokinetics provide flexibility for dose adjustments according to dietary intake and lifestyle.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Mysulin R Injection 100 IU/ml is indicated for:

• Type 1 diabetes mellitus – for basal-prandial insulin therapy to control both fasting and postprandial glucose

• Type 2 diabetes mellitus – when oral antidiabetic medications are insufficient for maintaining glycemic control

• Management of hyperglycemia during illness, surgery, or stress in diabetic patients

• Acute management of high blood sugar in hospitalized patients or emergencies

This formulation is suitable for patients who require a concentrated insulin dose for precise glycemic control.

Key Benefits

• Rapid-acting insulin effectively controls post-meal blood sugar spikes

• High-concentration formulation allows lower injection volumes for improved comfort

• Recombinant DNA technology ensures high purity and reduced risk of immune reactions

• Predictable absorption and action provide reliable glucose management

• Compatible with subcutaneous injections or insulin pumps for precise delivery

Mysulin R 100 IU/ml improves blood sugar stability, reduces complications related to hyperglycemia, and supports better long-term outcomes for diabetic patients.

Dosage and Administration

• Dosage must be individualized based on blood glucose levels, diet, activity, and concurrent medications.

• Administer subcutaneously in the abdomen, thigh, or upper arm 15–30 minutes before meals.

• Can be administered intravenously in hospital settings under medical supervision for rapid glucose control.

• Rotate injection sites to prevent lipodystrophy and ensure consistent absorption.

• Frequent blood glucose monitoring is essential to prevent hypo- or hyperglycemia and to guide dose adjustments.

Precautions

• Monitor for hypoglycemia; early symptoms include sweating, shakiness, dizziness, and palpitations.

• Adjust dose during illness, dietary changes, increased physical activity, or stress.

• Inform your healthcare provider about all medications to avoid interactions affecting blood sugar.

• Pregnant or breastfeeding women should use this insulin under medical supervision.

• Always have a source of fast-acting sugar available to manage low blood sugar emergencies.

Possible Side Effects

Mysulin R Injection 100 IU/ml is generally well tolerated, though some patients may experience:

• Hypoglycemia (low blood sugar)

• Injection site reactions such as redness, swelling, or mild pain

• Weight gain with long-term therapy

• Rare allergic reactions, including rash, itching, or anaphylaxis

Most adverse effects are manageable with proper monitoring, dose adjustment, and adherence to the prescribed regimen.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store unopened vials in a refrigerator at 2–8°C. Do not freeze.

• Protect from light and moisture.

• Once opened, it can be kept at room temperature (below 30°C) for the period recommended by a physician.

• Keep out of reach of children.

Mysulin R Injection 100 IU/ml (Insulin Human [rDNA]) is a concentrated, rapid-acting insulin that provides precise postprandial glucose control, supporting safe and effective diabetes management for type 1 and type 2 patients.